These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6233636)

  • 1. Common mechanism of action of biochemically "specific" antidepressants.
    Potter WZ; Karoum F; Linnoila M
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):153-61. PubMed ID: 6233636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
    Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
    Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions.
    Linnoila M; Karoum F; Rosenthal N; Potter WZ
    Arch Gen Psychiatry; 1983 Jun; 40(6):677-80. PubMed ID: 6221709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of norepinephrine turnover by serotonergic drug in man.
    Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.
    Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ
    Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
    Roy A; Guthrie S; Karoum F; Pickar D; Linnoila M
    Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
    Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK
    Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antidepressant treatments on dopamine turnover in depressed patients.
    Linnoila M; Karoum F; Potter WZ
    Arch Gen Psychiatry; 1983 Sep; 40(9):1015-7. PubMed ID: 6225405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific norepinephrine and serotonin uptake inhibitors in man: a crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parameters.
    Potter WZ; Calil HM; Extein I; Gold PW; Wehr TA; Goodwin FK
    Acta Psychiatr Scand Suppl; 1981; 290():152-65. PubMed ID: 6452790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of clorgyline on noradrenergic function.
    Ross RJ; Scheinin M; Lesieur P; Rudorfer MV; Hauger RL; Siever LJ; Linnoila M; Potter WZ
    Psychopharmacology (Berl); 1985; 85(2):227-30. PubMed ID: 3925487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.
    Chalon SA; Granier LA; Vandenhende FR; Bieck PR; Bymaster FP; Joliat MJ; Hirth C; Potter WZ
    Neuropsychopharmacology; 2003 Sep; 28(9):1685-93. PubMed ID: 12784100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo.
    Pawłowski L; Mazela H
    J Pharm Pharmacol; 1984 Dec; 36(12):855-8. PubMed ID: 6151986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
    Grossman F; Potter WZ
    Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
    Golden RN; Markey SP; Risby ED; Rudorfer MV; Cowdry RW; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):150-4. PubMed ID: 3122700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).
    Mooney JJ; Samson JA; Hennen J; Pappalardo K; McHale N; Alpert J; Koutsos M; Schildkraut JJ
    J Psychiatr Res; 2008 Jul; 42(8):605-11. PubMed ID: 17727882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.